ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years

Ruihan Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4095-5533; OpenAlex author ID A5069465471. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Integrated chromosomal instability and tumor microbiome redefined prognosis-related subtypes of pancreatic cancer. Co-author DOI 10.1016/j.hbpd.2024.03.002 ↗
Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages. Co-author DOI 10.1111/jcmm.16281 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shi Feng · 2 shared papers, 2021–2024 · strength 0.35
- Paper Integrated chromosomal instability and tumor microbiome redefined prognosis-related subtypes of pancreatic cancer. DOI 10.1016/j.hbpd.2024.03.002 ↗
- Paper Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages. DOI 10.1111/jcmm.16281 ↗
Qi Ling · 2 shared papers, 2021–2024 · strength 0.35
- Paper Integrated chromosomal instability and tumor microbiome redefined prognosis-related subtypes of pancreatic cancer. DOI 10.1016/j.hbpd.2024.03.002 ↗
- Paper Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages. DOI 10.1111/jcmm.16281 ↗
Xueyou Zhang · 1 shared paper, 2021 · strength 0.12
- Paper Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages. DOI 10.1111/jcmm.16281 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.